Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

7,998 public trials 712 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin

NCT01570751

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Mesa, Arizona, United States
  • Novo Nordisk Investigational Site Fresno, California, United States
  • Novo Nordisk Investigational Site Greenbrae, California, United States
  • Novo Nordisk Investigational Site San Ramon, California, United States
View all 46 locations
View Trial Details
Completed

Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus

NCT01364428

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Huntsville, Alabama, United States
  • Novo Nordisk Investigational Site Goodyear, Arizona, United States
  • Novo Nordisk Investigational Site Mesa, Arizona, United States
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
View all 45 locations
View Trial Details
Completed

MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin

NCT01792518

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • Boehringer Ingelheim Investigational Site Long Beach, California, United States
  • Boehringer Ingelheim Investigational Site North Hollywood, California, United States
  • Boehringer Ingelheim Investigational Site Denver, Colorado, United States
View all 74 locations
View Trial Details
Completed

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

NCT01068678

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Northridge, California, United States
  • Novo Nordisk Investigational Site Palm Springs, California, United States
  • Novo Nordisk Investigational Site Paramount, California, United States
  • Novo Nordisk Investigational Site Santa Ana, California, United States
View all 99 locations
View Trial Details
Completed

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

NCT01076647

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Peoria, Arizona, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site Beverly Hills, California, United States
View all 105 locations
View Trial Details
Completed

Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus

NCT01326026

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Huntsville, Alabama, United States
  • Novo Nordisk Investigational Site Anaheim, California, United States
  • Novo Nordisk Investigational Site La Jolla, California, United States
View all 45 locations
View Trial Details
Completed

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

NCT01068665

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Huntsville, Alabama, United States
  • Novo Nordisk Investigational Site Gilbert, Arizona, United States
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
View all 116 locations
View Trial Details
Completed

Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

NCT01388361

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Concord, California, United States
  • Novo Nordisk Investigational Site La Jolla, California, United States
  • Novo Nordisk Investigational Site Lancaster, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
View all 124 locations
View Trial Details
Completed

Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin

NCT01046110

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Huntsville, Alabama, United States
  • Novo Nordisk Investigational Site Concord, California, United States
  • Novo Nordisk Investigational Site Fresno, California, United States
  • Novo Nordisk Investigational Site Greenbrae, California, United States
View all 93 locations
View Trial Details
Completed

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes Mellitus

NCT02000700

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Little Rock, Arkansas, United States
  • Los Angeles, California, United States
  • Aurora, Colorado, United States
  • New Haven, Connecticut, United States
View all 17 locations
View Trial Details

Related conditions